GRPR antagonist protects from drug-induced liver injury by impairing neutrophil chemotaxis and motility

  • Rafael S. Czepielewski, Natália Jaeger, Pedro E. Marques, Maísa M. Antunes, Maurício M. Rigo, Débora M. Alvarenga, Rafaela V. Pereira, Rodrigo D. da Silva, Tiago G. Lopes, Vinícius D. da Silva, Bárbara N. Porto, Gustavo B. Menezes, Cristina Bonorino
  • European Journal of Immunology, April 2017, Wiley
  • DOI: 10.1002/eji.201646394

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1002/eji.201646394

The following have contributed to this page: Prof. Vinicius D da Silva

In partnership with: